GLANVAC 6 COMBINED CASEOUS LYMPHADENTITIS (CLA) - ENTEROTOXAEMIA (PULPY KIDNEY) - TETANUS (VETERINARY) - BLACKDISEASE - MALIGNAN

Main information

  • Trade name:
  • GLANVAC 6 COMBINED CASEOUS LYMPHADENTITIS (CLA) - ENTEROTOXAEMIA (PULPY KIDNEY) - TETANUS (VETERINARY) - BLACKDISEASE - MALIGNAN
  • Class:
  • Veterinary Medicine
  • Medicine domain:
  • Animals
  • Medicine type:
  • Allopathic drug

Documents

Localization

  • Available in:
  • GLANVAC 6 COMBINED CASEOUS LYMPHADENTITIS (CLA) - ENTEROTOXAEMIA (PULPY KIDNEY) - TETANUS (VETERINARY) - BLACKDISEASE - MALIGNAN
    Australia
  • Language:
  • English

Therapeutic information

  • Therapeutic group:
  • GOAT | GOAT KID | LAMB | SHEEP | SHEEP RAM (MALE) | BILLY | BUCK | CAPRA HIRCUS | DOE | EWE | HOGGET | KID | LAMB | OVINE | RAM
  • Therapeutic area:
  • IMMUNOTHERAPY
  • Therapeutic indications:
  • BLACK DISEASE | BLACKLEG | CHEESY GLAND | ENTEROTOXAEMIA (PULPY KIDNEY) | MALIGNANT OEDEMA | SWELLED HEAD | TETANUS | CLOSTRIDIUM PERFRINGENS TYPE D | LYMPHADENITIS | LYMPHANGITIS | TETANUS VACCINATION

Other information

Status

  • Source:
  • Australian Pesticides and Veterinary Medicines Authority (APVMA)
  • Authorization status:
  • Archived
  • Authorization number:
  • 36577
  • Last update:
  • 09-08-2016